- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lean oncology: a new model for oncologists ; volume:10 ; number:1 ; day:25 ; month:4 ; year:2012 ; pages:1-3 ; date:12.2012
Journal of translational medicine ; 10, Heft 1 (25.4.2012), 1-3, 12.2012
- Creator
-
Montesarchio, Vincenzo
- Contributor
-
Grimaldi, Antonio Maria
Fox, Bernard A.
Rea, Antonio
Marincola, Francesco M.
Ascierto, Paolo A.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-10-74
- URN
-
urn:nbn:de:1111-2016041441086
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Montesarchio, Vincenzo
- Grimaldi, Antonio Maria
- Fox, Bernard A.
- Rea, Antonio
- Marincola, Francesco M.
- Ascierto, Paolo A.
- SpringerLink (Online service)
Other Objects (12)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Radiology reporting in oncology—oncologists’ perspective
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The influence of diet on anti-cancer immune responsiveness
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Radiology reporting in oncology—oncologists’ perspective
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The influence of diet on anti-cancer immune responsiveness
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Radiology reporting in oncology—oncologists’ perspective
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The influence of diet on anti-cancer immune responsiveness